{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:29:31Z","timestamp":1776288571397,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier","isbn-type":[{"value":"9780128239124","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/b978-0-12-823912-4.00016-5","type":"book-chapter","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T06:14:28Z","timestamp":1710483268000},"page":"419-429","source":"Crossref","is-referenced-by-count":1,"title":["Hematologic malignancies and hematopoietic stem cell transplantation"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2020007039","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","volume":"137","author":"Agathangelidis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00167070","article-title":"Paraneoplastic cerebellar degeneration associated with multiple myeloma\u20143.4 years follow up","volume":"9","author":"Akpinar","year":"1990","journal-title":"J Neurooncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0020","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0025","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41409-021-01395-7","article-title":"Poems syndrome: consolidation with autologous stem cell transplantation","volume":"56","author":"Baa","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-020-00919-6","article-title":"Diagnostic and therapeutic considerations for extramedullary leukemia","volume":"22","author":"Bakst","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/CCO.0000000000000403","article-title":"Role of stem cell transplant in lymphoma in the era of new drugs","volume":"29","author":"Benekou","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0055","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","article-title":"Spectrum of paraneoplastic disease associated with lymphoma","volume":"76","author":"Briani","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0065","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.3324\/haematol.2016.153064","article-title":"Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients","volume":"102","author":"Briani","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12295","article-title":"Peripheral nervous system involvement in lymphomas","volume":"24","author":"Briani","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/brainsci11020132","article-title":"Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies","volume":"11","author":"Briani","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jns.12371","article-title":"Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: experience beyond the clinical trials","volume":"25","author":"Bruna","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0085","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","article-title":"The Ophelia syndrome: memory loss in Hodgkin's disease","volume":"1","author":"Carr","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","article-title":"Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration","volume":"71","author":"de Graaff","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420985323","article-title":"Paraneoplastic neurological syndromes: clinical presentations and management","volume":"14","author":"Devine","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0110","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.clml.2014.02.006","article-title":"Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination","volume":"14","author":"DeVito","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0115","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.26240","article-title":"POEMS syndrome: 2021 update on diagnosis, risk-stratification, and management","volume":"96","author":"Dispenzieri","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.25708","article-title":"Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4103\/1673-5374.233431","article-title":"Neurological complications of hematopoietic cell transplantation in children and adults","volume":"13","author":"Dulamea","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11060-018-2752-5","article-title":"Neurologic complications of immune checkpoint inhibitors","volume":"137","author":"Fellner","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0135","first-page":"570","article-title":"Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome","volume":"75","author":"Ferrari","year":"1990","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/mus.23464","article-title":"Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma","volume":"46","author":"Flanagan","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.33588\/rn.4803.2008217","article-title":"Opsoclonus-myoclonus-ataxia syndrome: two anatomo-clinical case reports","volume":"48","author":"Gabaldon-Torres","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/B978-0-444-53502-3.00028-8","article-title":"Paraneoplastic disorders of the peripheral nervous system","volume":"105","author":"Giometto","year":"2012","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0160","first-page":"CD007625","article-title":"Treatment for paraneoplastic neuropathies","volume":"12","author":"Giometto","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","article-title":"Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"74","author":"Graus","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010050853","article-title":"Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system","volume":"96","author":"Graus","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0180","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0185","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","article-title":"Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas","volume":"123","author":"Graus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0190","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaneurol.2014.999","article-title":"Antibodies to Delta\/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma","volume":"71","author":"Greene","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00381-016-3284-y","article-title":"Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature","volume":"33","author":"Gungor","year":"2017","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11121577","article-title":"Anti-Ma2 antibody-associated paraneoplastic neurological syndromes: a pilot study","volume":"11","author":"Guo","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0210","first-page":"ECR59","article-title":"Paraneoplastic stiff-person syndrome, heterotopic soft tissue ossification and gonarthritis in a HLA B27-positive woman preceding the diagnosis of Hodgkin's lymphoma","volume":"91","author":"Gutmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/102476","article-title":"MPNs as inflammatory diseases: the evidence, consequences, and perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jnnp.29.1.45","article-title":"Cerebellar degeneration with Hodgkin's disease","volume":"29","author":"Horwich","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0225","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00019052-199410000-00004","article-title":"Guillain-Barre syndrome","volume":"7","author":"Hughes","year":"1994","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","article-title":"Outcomes of patients with POEMS syndrome treated initially with radiation","volume":"122","author":"Humeniuk","year":"2013","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0235","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jcyt.2021.12.006","article-title":"Hematopoietic stem cell transplantation for uncommon immune-mediated neurological disorders: a literature review","volume":"24","author":"Jaime-Perez","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12974-016-0737-x","article-title":"Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0245","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41409-019-0430-7","volume":"54","author":"Jessop","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0250","first-page":"362","article-title":"Paraneoplastic neurological syndrome: an evolving story","volume":"8","author":"Jitprapaikulsan","year":"2021","journal-title":"Neurooncol Pract"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clml.2021.10.007","article-title":"POEMS syndrome: real world experience in diagnosis and systemic therapy\u2014108 patients multicenter analysis","volume":"22","author":"Jurczyszyn","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0260","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/bloodadvances.2022007218","article-title":"Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma","volume":"6","author":"Kansagra","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0265","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","article-title":"Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome: a review","volume":"7","author":"Khouri","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0270","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2169\/internalmedicine.7180-21","article-title":"Nodal peripheral T-cell lymphoma with T follicular helper phenotype presenting as chorea during treatment: a case report and literature review","volume":"60","author":"Kitamura","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2018.06.029","article-title":"Possible neuroleukemiosis in two patients with acute myeloid leukemia in complete bone marrow remission","volume":"392","author":"Kostic","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0280","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","article-title":"Autoimmunity and the risk of myeloproliferative neoplasms","volume":"95","author":"Kristinsson","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11060-004-2465-9","article-title":"Paraneoplastic Opsoclonus-myoclonus syndrome: initial presentation of non-Hodgkins lymphoma","volume":"73","author":"Kumar","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0290","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1080\/10428194.2021.1927022","article-title":"Paraneoplastic cerebellar degeneration in a patient with multiple myeloma","volume":"62","author":"Kurtuncu","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0295","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0300","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/diagnostics12040998","article-title":"POEMS syndrome: presented as idiopathic multicentric Castleman disease of plasma cell variant for eight years and dramatic treatment with siltuximab followed by autologous peripheral blood stem cell transplantation","volume":"12","author":"Lee","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410010107","article-title":"Guillain-Barre syndrome and Hodgkin's disease: three cases with immunological studies","volume":"1","author":"Lisak","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0310","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene Ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0315","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clml.2011.10.005","article-title":"Spectrum of neurologic complications in chronic lymphocytic leukemia","volume":"12","author":"Lopes da Silva","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0320","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2021.07.001","article-title":"Adult-type dermatomyositis with secondary lymphoid follicles harbouring reactive B-cells component","volume":"31","author":"Maghrabi","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hemonc.2017.05.009","article-title":"Long-term complications after hematopoietic cell transplantation","volume":"10","author":"Majhail","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0330","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0335","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0b013e31828ab325","article-title":"Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF","volume":"80","author":"Mat","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.26362","article-title":"Human metabotropic glutamate receptor 5 antibodies alter receptor levels and behavior in mice","volume":"92","author":"Maudes","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0345","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000987","article-title":"Autoantibodies against the Purkinje cell protein RGS8 in paraneoplastic cerebellar syndrome","volume":"8","author":"Miske","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00687433","article-title":"Paraneoplastic cortical cerebellar degeneration. A neuropathological study of an autopsy case in comparison with cortical cerebellar degeneration in alcoholics","volume":"77","author":"Mizutani","year":"1988","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0355","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.braindev.2018.10.006","article-title":"Severe anti-GAD antibody-associated encephalitis after stem cell transplantation","volume":"41","author":"Nagai","year":"2019","journal-title":"Brain Dev"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2019.11.009","article-title":"Pediatric paraneoplastic necrotizing encephalitis associated with acute lymphoblastic leukemia","volume":"105","author":"Nguyen","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0365","article-title":"Improvement of paraneoplastic limbic encephalitis after systemic treatment with rituximab in a patient with B-cell chronic lymphocytic leukemia","volume":"2013","author":"Nogai","year":"2013","journal-title":"Case Rep Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0370","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.14966","article-title":"Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial","volume":"179","author":"Nozza","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0375","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune chorea in adults","volume":"80","author":"O'Toole","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0380","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17474086.2021.1977119","article-title":"Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update","volume":"14","author":"Pierri","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0385","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000068","article-title":"Standardized test for anti-Tr\/DNER in patients with paraneoplastic cerebellar degeneration","volume":"2","author":"Probst","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0390","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/WNL.0000000000000865","article-title":"Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia","volume":"83","author":"Pruss","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0395","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0400","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0405","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1080\/10428194.2018.1564048","article-title":"Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients","volume":"60","author":"Riva","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0410","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000658","article-title":"Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2","volume":"7","author":"Ruiz-Garcia","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0415","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-3083.2004.01069.x","article-title":"Paraneoplastic vasculitis associated with multiple myeloma","volume":"18","author":"Sanchez","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0420","article-title":"Myasthenia gravis and myeloproliferative neoplasms\u2014mere association or paraneoplastic neurologic syndrome: a mini-review","volume":"92","author":"Sasi","year":"2022","journal-title":"Acta Biomed"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0425","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/B:NEON.0000003754.34527.f2","article-title":"Anti-GAD antibody positive stiff-limb syndrome in multiple myeloma","volume":"65","author":"Schiff","year":"2003","journal-title":"J Neurooncol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.410050310","article-title":"Subacute motor neuronopathy: a remote effect of lymphoma","volume":"5","author":"Schold","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0435","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001124","article-title":"Population-based epidemiology study of paraneoplastic neurologic syndromes","volume":"9","author":"Shah","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0440","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0445","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41409-020-01199-1","volume":"56","author":"Sharma","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100910","article-title":"Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities","volume":"53","author":"Siegal","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0460","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41409-019-0718-7","volume":"55","author":"Snowden","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0465","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/s41409-021-01467-8","article-title":"Visions for a JACIE quality management system 4.0","volume":"56","author":"Snowden","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0470","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0475","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0480","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3324\/haematol.2015.136556","article-title":"Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia","volume":"101","author":"Strati","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0485","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2015.06.003","article-title":"Lymphoma-associated dysimmune polyneuropathies","volume":"355","author":"Stubgen","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0490","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-021-05992-1","article-title":"Eyelid erythema as the first manifestation of subcutaneous panniculitis-like T-cell lymphoma mimicking dermatomyositis: a case-based review","volume":"41","author":"Sun","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0495","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0500","first-page":"421","article-title":"Myeloproliferative disorders\u2014neurological complications","volume":"6","author":"Tarach","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0505","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1002\/ajh.26517","article-title":"Single-agent daratumumab for refractory POEMS syndrome","volume":"97","author":"Tiew","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0510","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12185-020-02859-0","article-title":"Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation","volume":"112","author":"Toda","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0515","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","article-title":"Cerebellar degeneration with Hodgkin disease. An immunological study","volume":"33","author":"Trotter","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0520","first-page":"18","article-title":"Lambert-Eaton myaesthenic syndrome: a possible association with Hodgkin's lymphoma","volume":"94","author":"Tyagi","year":"2001","journal-title":"Ir Med J"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0525","first-page":"246","article-title":"Case report: cerebellar degeneration with Hodgkin's disease","volume":"29","author":"Valtysson","year":"1979","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0530","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","article-title":"Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma","volume":"51","author":"Vernino","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0535","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0540","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2016.11.020","article-title":"Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients","volume":"72","author":"Visentin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0545","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41416-019-0502-x","article-title":"The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia","volume":"121","author":"Visentin","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061562","article-title":"From biology to treatment of monoclonal gammopathies of neurological significance","volume":"14","author":"Visentin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0555","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2021.278304","article-title":"The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation","volume":"107","author":"Visentin","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0560","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1002\/ajh.26437","article-title":"Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: a real-life campus CLL study","volume":"97","author":"Visentin","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0565","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood.2020008201","article-title":"Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs","volume":"137","author":"Vitale","year":"2021","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2019.100005","article-title":"Cytokines frequently implicated in myeloproliferative neoplasms","volume":"1","author":"Wang","year":"2019","journal-title":"Cytokine X"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0575","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00718025","article-title":"Paraneoplastic cerebellar degeneration associated with Hodgkin's disease","volume":"235","author":"Wessel","year":"1987","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248011","article-title":"Myasthenia gravis associated with a pelvic follicular lymphoma","volume":"15","author":"Willis","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0585","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41375-019-0391-2","article-title":"What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?","volume":"33","author":"Zhao","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/B978-0-12-823912-4.00016-5_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.706169","article-title":"Paraneoplastic neuropathies: what's new since the 2004 recommended diagnostic criteria","volume":"12","author":"Zoccarato","year":"2021","journal-title":"Front Neurol"}],"container-title":["Handbook of Clinical Neurology","Paraneoplastic Neurologic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128239124000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128239124000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:18:30Z","timestamp":1753967910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128239124000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780128239124"],"references-count":117,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-823912-4.00016-5","relation":{},"ISSN":["0072-9752"],"issn-type":[{"value":"0072-9752","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}